Related Experiment Video

Updated: Aug 11, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells

N W C J van de Donk1, M M J Kamphuis, H M Lokhorst

  • 1Department of Immunology, University Medical Center Utrecht, The Netherlands.

Leukemia
|July 3, 2002
PubMed

Insights

Lovastatin, an HMG-CoA reductase inhibitor, reduces plasma cell viability by inducing apoptosis and inhibiting proliferation. This cholesterol-lowering drug shows promise for treating multiple myeloma, especially when combined with other therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • HMG-CoA reductase inhibition by lovastatin blocks mevalonate production, impacting cholesterol and isoprenoid synthesis.
  • Isoprenylation of proteins like Ras is crucial for cell signaling and membrane localization.

Purpose of the Study:

  • To investigate the effect of lovastatin on plasma cell viability and its underlying mechanisms.
  • To explore the potential of lovastatin, alone or in combination, for multiple myeloma treatment.

Main Methods:

  • Assessed lovastatin's dose- and time-dependent effects on plasma cell viability using cell lines and patient samples.
  • Investigated the synergistic effects of lovastatin with dexamethasone.
  • Analyzed changes in apoptosis, proliferation, and protein localization (Ras).

Main Results:

  • Lovastatin significantly decreased plasma cell viability through apoptosis induction and proliferation inhibition.
  • Co-incubation with dexamethasone showed a synergistic cytotoxic effect.
  • Mevalonate reversed lovastatin's cytotoxic and cytostatic effects, and Ras shifted from membrane to cytosol.

Conclusions:

  • Lovastatin demonstrates significant cytotoxic and cytostatic effects on plasma cells.
  • Lovastatin holds potential as a therapeutic agent for multiple myeloma, warranting further clinical investigation.
  • Combination therapy with lovastatin may enhance treatment efficacy in myeloma patients.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...